chartexchange

Unicycive Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire Inc. | Nov 16, 2026 7:05 AM EST

MOUNTAIN VIEW, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the third quarter ended September 30, 2026, and provided a business update .

Read original article